tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BRRGF Stock Latest News

BerGenBio Continues Strategic Review and Ends Bemcentinib Development
Company AnnouncementsBerGenBio Continues Strategic Review and Ends Bemcentinib Development
22d ago
BerGenBio ASA Announces Virtual Annual General Meeting
PremiumCompany Announcements
BerGenBio ASA Announces Virtual Annual General Meeting
22d ago
BerGenBio ASA Approves 2024 Financial Statements Amid Strategic Review
PremiumCompany Announcements
BerGenBio ASA Approves 2024 Financial Statements Amid Strategic Review
2M ago
BerGenBio’s Bemcentinib Shows Promise in AML Treatment
PremiumCompany Announcements
BerGenBio’s Bemcentinib Shows Promise in AML Treatment
3M ago
BerGenBio Engages Financial Advisor for Strategic Alternatives Exploration
PremiumCompany Announcements
BerGenBio Engages Financial Advisor for Strategic Alternatives Exploration
3M ago
BerGenBio Reports Q4 2024 Results Amid Strategic Shift
PremiumCompany AnnouncementsBerGenBio Reports Q4 2024 Results Amid Strategic Shift
4M ago
BerGenBio ASA Closes Cancer Study Amid Financial Challenges
Premium
Company Announcements
BerGenBio ASA Closes Cancer Study Amid Financial Challenges
4M ago
BerGenBio ASA Discontinues Lung Cancer Study, Explores Strategic Options
Premium
Company Announcements
BerGenBio ASA Discontinues Lung Cancer Study, Explores Strategic Options
4M ago
BRRGF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
BRRGF Earnings this Week: How Will it Perform?
4M ago
BerGenBio Initiates Clinical Trial for Promising Lung Cancer Treatment
PremiumCompany Announcements
BerGenBio Initiates Clinical Trial for Promising Lung Cancer Treatment
6M ago
BerGenBio Highlights Clinical Progress and Strategy
PremiumCompany Announcements
BerGenBio Highlights Clinical Progress and Strategy
7M ago
BerGenBio ASA Appoints New CEO to Lead Growth
PremiumCompany Announcements
BerGenBio ASA Appoints New CEO to Lead Growth
7M ago
BerGenBio Reports Q3 2024 Earnings and Strategy Updates
PremiumCompany AnnouncementsBerGenBio Reports Q3 2024 Earnings and Strategy Updates
7M ago
BerGenBio Reports Progress in Cancer Drug Development
Premium
Company Announcements
BerGenBio Reports Progress in Cancer Drug Development
7M ago
Is BRRGF a Buy, Before Earnings?
Premium
Pre-Earnings
Is BRRGF a Buy, Before Earnings?
8M ago
BerGenBio ASA CEO Martin Olin Steps Down
PremiumCompany Announcements
BerGenBio ASA CEO Martin Olin Steps Down
9M ago
BerGenBio ASA’s Extraordinary Meeting Concludes Successfully
PremiumCompany Announcements
BerGenBio ASA’s Extraordinary Meeting Concludes Successfully
9M ago
BerGenBio’s Bemcentinib Shows Promise in Lung Cancer Study
PremiumCompany Announcements
BerGenBio’s Bemcentinib Shows Promise in Lung Cancer Study
9M ago
BerGenBio ASA Announces Virtual Extraordinary Meeting
PremiumCompany Announcements
BerGenBio ASA Announces Virtual Extraordinary Meeting
9M ago
BerGenBio ASA Presents at Global Investment Conference
PremiumCompany AnnouncementsBerGenBio ASA Presents at Global Investment Conference
10M ago
BerGenBio target adjusted to NOK 38 from NOK 70 at H.C. Wainwright
Premium
The Fly
BerGenBio target adjusted to NOK 38 from NOK 70 at H.C. Wainwright
10M ago
BerGenBio Solidifies Clinical Trials and Finances
Premium
Company Announcements
BerGenBio Solidifies Clinical Trials and Finances
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >